Unknown

Dataset Information

0

Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.


ABSTRACT: Maple syrup urine disease (MSUD; OMIM 248600) is an inborn error of metabolism of the branched chain alpha-ketoacid dehydrogenase (BCKDH) complex that is treated primarily by dietary manipulation of branched-chain amino acids (BCAA). Dietary restriction is lifelong and compliance is difficult. Liver transplantation significantly improves outcomes; however, alternative therapies are needed. To test novel therapies such as hepatocyte transplantation (HTx), we previously created a murine model of intermediate MSUD (iMSUD), which closely mimics human iMSUD. LacZ-positive murine donor hepatocytes were harvested and directly injected (10(5) cells/50 microl) into liver of iMSUD mice (two injections at 1-10 days of age). Donor hepatocytes engrafted into iMSUD recipient liver, increased liver BCKDH activity, improved blood total BCAA/alanine ratio, increased body weight at weaning, and extended the lifespan of HTx-treated iMSUD mice compared to phosphate-buffered saline (PBS)-treated and untreated iMSUD mice. Based on these data demonstrating partial metabolic correction of iMSUD in a murine model, coupled to the fact that multiple transplants are possible to enhance these results, we suggest that HTx represents a promising therapeutic intervention for MSUD that warrants further investigation.

SUBMITTER: Skvorak KJ 

PROVIDER: S-EPMC2835204 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.

Skvorak Kristen J KJ   Paul Harbhajan S HS   Dorko Kenneth K   Marongiu Fabio F   Ellis Ewa E   Chace Donald D   Ferguson Carolyn C   Gibson K Michael KM   Homanics Gregg E GE   Strom Stephen C SC  

Molecular therapy : the journal of the American Society of Gene Therapy 20090512 7


Maple syrup urine disease (MSUD; OMIM 248600) is an inborn error of metabolism of the branched chain alpha-ketoacid dehydrogenase (BCKDH) complex that is treated primarily by dietary manipulation of branched-chain amino acids (BCAA). Dietary restriction is lifelong and compliance is difficult. Liver transplantation significantly improves outcomes; however, alternative therapies are needed. To test novel therapies such as hepatocyte transplantation (HTx), we previously created a murine model of i  ...[more]

Similar Datasets

| S-EPMC2753721 | biostudies-literature
| S-EPMC3593790 | biostudies-literature
| S-EPMC8102797 | biostudies-literature
| S-EPMC9979284 | biostudies-literature
| S-EPMC7603684 | biostudies-literature
| S-EPMC9795541 | biostudies-literature
| S-EPMC3024040 | biostudies-literature
| S-EPMC5593394 | biostudies-literature
| S-EPMC1234918 | biostudies-literature
| S-EPMC10448551 | biostudies-literature